New rabies vaccine passes first safety check in small study
NCT ID NCT07338786
First seen Jan 15, 2026 · Last updated May 01, 2026 · Updated 20 times
Summary
This early-stage study is testing whether a new freeze-dried rabies vaccine is safe for people aged 10 to 60. Eighty healthy volunteers will receive the vaccine and be monitored for side effects for 30 days. The goal is to prevent rabies, not to treat it after exposure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIESPREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangsu CDC
Xuzhou, Jiangsu, China
Conditions
Explore the condition pages connected to this study.